Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-06

Clinical Trial Update: Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the combination of intravenous ceftriaxone and oral doxycycline for Lyme neuroborreliosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxycycline (Doxycycline)
  • ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: Sorlandet Hospital HF | Conditions: Lyme Neuroborreliosis | Phase 3 | Status: COMPLETED